Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-1.79%
Change (1 year)
Categories
Rigel Pharmaceuticals (RIGL) - Total debt
Total debt on the balance sheet as of December 2023 : $60.57 M
According to Rigel Pharmaceuticals's latest financial reports the company's total debt is $60.57 M. A company’s total debt is the sum of all current and non-current debts.
Rigel Pharmaceuticals - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $60.57 M | 45.79% |
| 2022-12-31 | $41.55 M | 35.95% |
| 2021-12-31 | $30.56 M | -21.8% |
| 2020-12-31 | $39.08 M | 7.64% |
| 2019-12-31 | $36.31 M | |
| 2018-12-31 | $N/A | |
| 2011-12-31 | $N/A | -100% |
| 2010-12-31 | $0.8 M | -58.85% |
| 2009-12-31 | $1.94 M | -42.69% |
| 2008-12-31 | $3.39 M | 91.21% |
| 2007-12-31 | $1.77 M | -24.54% |
| 2006-12-31 | $2.35 M | 6.77% |
| 2005-12-31 | $2.2 M | 4.76% |
| 2004-12-31 | $2.1 M | -39.86% |
| 2003-12-31 | $3.49 M | -38.69% |
| 2002-12-31 | $5.7 M | -23.1% |
| 2001-12-31 | $7.41 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $64.61 B | 106,559.07% | 🇺🇸 USA |
 AstraZeneca AZN | $34.55 B | 56,934.62% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | $38.1 M | -37.10% | 🇺🇸 USA |
 ChemoCentryx CCXI | N/A | N/A | 🇺🇸 USA |